Organon & Co. (OGN)

Organon & Co. (OGN) is a healthcare company (drug manufacturers - general) based in the United States. The share price is $13.90, up 0.00% on the day, which values the company at $3.65B. Price as of 17 Nov 2026, 17:28 UTC, from Yahoo Finance.

Key facts

Share price
$13.90+0.00% today
Market value
$3.65B
P/E ratio
17.8×last 12 months
Forward P/E
3.8×
Dividend yield
0.58%
Funk Score
27/100
Against its own history
Well above its usual priceusual price $9.68
200-week average
$15.269% below

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Organon & Co. in more detail

OGN trades at 17.8× its last twelve months' earnings, 3.8× next year's expected earnings, 0.6× sales. Measured against its own history, the price is 44% above what its usual multiples would imply ($9.68) — well above its usual price. It sits 9% below its 200-week average of $15.26.

Over the last five fiscal years Organon & Co. has compounded revenue -1.0% a year, earnings per share -39.0% a year, free cash flow -28.3% a year. Its Funk Score is 27 out of 100 (financial strength 1.5, profitability 4.5, growth 1.3, value 3.6, each out of 10).

Worth checking: Altman Z in the distress zone; Share count keeps rising.

3 of the superinvestors tracked here hold OGN, including Thomas Kahn (3.2% of the portfolio), George Soros (0.6% of the portfolio), Charles Brandes (founder) (0.1% of the portfolio).

Superinvestors holding OGN

3 of the investors tracked here report a position in their latest 13F filing.

Organon & Co. (OGN): questions and answers

What is OGN's P/E ratio?

Organon & Co. trades at 17.8× its last twelve months' earnings and 3.8× next year's expected earnings. At its fiscal year-ends over the past 5 years the P/E ranged from 3.6× to 10.0×, with a median of 5.7×.

What is Organon & Co.'s market cap?

Organon & Co. is valued at $3.65B at a share price of $13.90.

Is OGN overvalued or undervalued?

Against its own history, OGN is well above its usual price: the price is 44% above the $9.68 implied by the median multiples it has traded at (price / earnings, price / sales, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is OGN above its 200-week moving average?

No. OGN is 8.9% below its 200-week average of $15.26. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Organon & Co. growing?

Over the last five fiscal years Organon & Co.'s revenue grew -1.0% a year and its earnings per share -39.0% a year.

Does OGN pay a dividend?

Yes. Organon & Co.'s dividend yield is 0.58%, or $0.08 a share a year, paying out 10% of earnings.

Cite this page

Funkfolio, “Organon & Co. (OGN) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/OGN

Underlying data: Yahoo Finance; company filings with the SEC.